Clinical Trial Update: Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Decadron, Biaxin, and pomalidomide in relapsed/refractory multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Biaxin (clarithromycin)
• Decadron (Dexamethasone)
• Pomalist (pomalidomide)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2017-04-12